论文部分内容阅读
晚期肝、胃癌患者,进行动脉灌注化疗药物,希望能收提高手术切除率,抑制和延缓癌的复发等效果,其毒副作用亦比全身静脉给药较少而轻。病例报告例1 邬某,女,47岁,工人。1979年6月发觉进食有梗阻感,经钡餐和胃镜活检证实为贲门腺癌。胃镜不能通过贲门。1979年8年21日行胸腹联合切口探查术,见胃病变广泛,无法切除,乃采用胃网膜左动脉插管化疗(5-Fu500mg,TS PA10mg,MMC4mg),隔日一次。术中术后共灌注5
Patients with advanced liver and stomach cancer undergo arterial infusion of chemotherapeutic drugs, hoping to increase the rate of surgical resection, suppress and delay the recurrence of cancer, and have fewer toxic side effects than systemic intravenous administration. Case Report Case 1 A certain female, female, 47 years old, worker. In June 1979, a sense of obstruction was found in eating, which was confirmed by barium meal and gastroscope biopsy. Gastroscopes can’t go through the tricks. On Jun. 8, 1979, chest and abdomen combined incision exploration was performed. The gastric lesions were extensive and could not be removed. The patients were treated with chemotherapy (5-Fu 500mg, TS PA10mg, MMC 4mg) with left gastroepiplitic artery, every other day. Intraoperative total perfusion 5